CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Adaptimmune Therapeutics PLC

ADAPY
$7MMicro Cap

Next catalyst

No upcoming catalyst in our data

No upcoming FDA decision, filing or trial readout is on file for ADAPY. That does not mean none is planned.

Get an email about ADAPY's next catalysts

Track Adaptimmune Therapeutics (ADAPY) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.

Catalyst Timeline

0 upcoming, 0 past

No catalysts found.

Market Overview

Stock performance and key metrics

NASDAQBiological Products, (No Diagnostic Substances)BiotechnologyπŸ‡ΊπŸ‡ΈNorth AmericaABINGDON, OXFORDSHIRE506 employees

Adaptimmune is a biopharmaceutical company that develops T cell therapies against cancer. The company was founded in 2008 in the UK with links to both Oxford University and the University of Pennsylvania. It has headquarters in Philadelphia and Milton Park.

Website
Drug Pipeline

Frequently asked questions

What is in Adaptimmune Therapeutics PLC's drug pipeline?β†’

CatalystAlert tracks 1 drug candidate in Adaptimmune Therapeutics PLC's (ADAPY) pipeline across Phase 2. Its lead program is NYESO-1c259 T cells (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.

When is Adaptimmune Therapeutics PLC's next FDA catalyst?β†’

CatalystAlert tracks every upcoming catalyst for Adaptimmune Therapeutics PLC (ADAPY) β€” PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings β€” each confidence-rated as confirmed, estimated or AI-detected.

How do I track ADAPY biotech catalysts?β†’

Add ADAPY to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Adaptimmune Therapeutics PLC's live catalyst calendar, drug pipeline and clinical-trial timeline on this page β€” sourced from ClinicalTrials.gov, FDA and SEC filings.

Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply